Cargando…

Metabolic Syndrome in Patients with Severe Mental Illness Undergoing Psychiatric Rehabilitation Receiving High Dose Antipsychotic Medication

BACKGROUND: To review evidence of chronic antipsychotic medication and the association with metabolic syndrome in mentally ill patients. This evidence was used to analyse a cohort of patients with severe mental illness and to deduce a correlation between the prevalence of metabolic syndrome and thei...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ravindranath, Bapu V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573576/ https://www.ncbi.nlm.nih.gov/pubmed/23439746 http://dx.doi.org/10.4103/0253-7176.106021

Ejemplares similares

Prevalence and Management of Metabolic Syndrome in Adult Psychiatric Patients Receiving Second-Generation Antipsychotics at Sheikh Khalifa Medical City
por: Mohammed, Wadha, et al.
Publicado: (2022)

Psychosocial rehabilitation for severe mental illnesses in general hospital psychiatric settings in South Asia
por: Sood, Mamta, et al.
Publicado: (2015)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
por: Velligan, Dawn I, et al.
Publicado: (2017)

Corynebacterium kroppenstedtii Is an Emerging Cause of Mastitis Especially in Patients With Psychiatric Illness on Antipsychotic Medication
por: Wong, Sally C. Y., et al.
Publicado: (2017)

Reducing the use of high dose antipsychotic medication in acute adult inpatient psychiatric units
por: Pantall, Shay-Anne, et al.
Publicado: (2021)

Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021)

Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS)
por: Mandarelli, Gabriele, et al.
Publicado: (2022)

High dose antipsychotic therapy (HDAT) in the Greater Manchester mental health adult psychiatric inpatient setting
por: Sparasci, Oli, et al.
Publicado: (2021)

Effectiveness of a complex psychosocial intervention to reduce metabolic syndrome in psychiatric outpatients with severe/persistent mental illness
por: Konkolÿ Thege, Barna, et al.
Publicado: (2021)

Brief intervervention for a metabolic syndrome in psychiatric outpatients with severe/persistent mental illness: A prospective study
por: Escarti, M., et al.
Publicado: (2023)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Optimization of antipsychotic use in the elderly with severe mental illness; a review of three cases.
por: Izquierdo De La Puente, A., et al.
Publicado: (2023)

The magnitude of undiagnosed diabetes and Hypertension among adult psychiatric patients receiving antipsychotic treatment
por: Hirigo, Agete Tadewos, et al.
Publicado: (2020)

Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics
por: Kaikoushi, Katerina, et al.
Publicado: (2021)

Cost Effectiveness and Budget Impact of the Boston University Approach to Psychiatric Rehabilitation for Increasing the Social Participation of Individuals With Severe Mental Illnesses
por: Sanches, Sarita A., et al.
Publicado: (2022)

Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study
por: Mitchell, Alex J., et al.
Publicado: (2019)

Psychosocial rehabilitation of people living with mental illness: Lessons learned from community-based psychiatric rehabilitation centres in Gujarat
por: Saha, Somen, et al.
Publicado: (2020)

Study of menstrual irregularities in patients receiving antipsychotic medications
por: Murke, Mukund P., et al.
Publicado: (2011)

Impact of SGLT2 inhibitors on metabolic status in patients with psychiatric disorders undergoing treatment with second‑generation antipsychotics (Review)
por: Vasiliu, Octavian
Publicado: (2023)

A behavioral weight loss intervention for persons with serious mental illness in psychiatric rehabilitation centers
por: Daumit, GL, et al.
Publicado: (2010)

Psychiatric rehabilitation through teaching smartphone skills to improve functional outcomes in serious mental illness
por: Rodriguez-Villa, Elena, et al.
Publicado: (2021)

Cognitive Remediation and Psychosocial Rehabilitation for Individuals with Severe Mental Illness
por: McGurk, Susan R., et al.
Publicado: (2012)

Metabolic syndrome in patients with severe mental illness in Gorgan
por: Kamkar, Mohammad Zaman, et al.
Publicado: (2016)

Improving physical health monitoring for patients with chronic mental health problems who receive antipsychotic medications
por: Abdallah, Nihad, et al.
Publicado: (2016)

Effectiveness of the Boston University Approach to Psychiatric Rehabilitation in Improving Social Participation in People With Severe Mental Illnesses: A Randomized Controlled Trial
por: Sanches, Sarita A., et al.
Publicado: (2020)

Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness
por: Forma, Felicia, et al.
Publicado: (2020)

Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis
por: Poojari, Pooja Gopal, et al.
Publicado: (2023)

Rehabilitation of mentally ill women
por: Chatterjee, Rajni, et al.
Publicado: (2015)

Stroke survivors with severe mental illness: Are they at-risk for increased non-psychiatric hospitalizations?
por: Lilly, Flavius Robert, et al.
Publicado: (2017)

Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
por: Endomba, Francky Teddy, et al.
Publicado: (2020)

Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
por: Gautam, Shiv, et al.
Publicado: (2011)

Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
por: Hammoudeh, Samer, et al.
Publicado: (2019)

Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
por: Younas, Mediha, et al.
Publicado: (2016)

Prescription of High Dose of Antipsychotics in Two Rehabilitation Wards of Chronically Unwell Patients
por: Liolitsa, Danae, et al.
Publicado: (2023)

Psychiatric treatment of mentally ill persons in custody – legal, medical and ethical issues
por: Jengic, V. Sendula, et al.
Publicado: (2021)

How patients with severe mental illness experience care provided by psychiatric mental health nurse practitioners
por: van Dusseldorp, Loes, et al.
Publicado: (2023)

antipsychotics and metabolic syndrome
por: Jomli, R., et al.
Publicado: (2022)

ECT IN MENTALLY RETARDED SUBJECTS WITH PSYCHIATRIC ILLNESS
por: Chopra, V.K, et al.
Publicado: (2002)

Personality and Mental Illness: An Essay in Psychiatric Diagnosis
Publicado: (1941)

Cannot write session to /tmp/vufind_sessions/sess_3no5k1kd2ppntipho6ohf7nstu